Dr. Robinson is the Director of the Preventive Research Center and has conducted numerous clinical trials of lipid-lowering, anti-atherosclerotic and metabolic agents, and postmenopausal hormone therapy sponsored by the National Institutes of Health and the pharmaceutical industry. She has published over 250 peer-reviewed articles in the area of lipids-modifying drugs, cardiovascular risk stratification, and cardiovascular prevention. Dr Robinson was the Vice Chair of the 2013 ACC/AHA Cholesterol Guideline, and a member of the 2013 ACC/AHA Risk Assessment Guideline. She has lectured widely on preventive cardiology and the diagnosis and treatment of lipid disorders.